Halozyme Therapeutics reported $128.4M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
DBV Technologies DBVT:US USD 20.09M 5.26M
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amarin AMRN:US USD 95.02M 62.25M
Amgen AMGN:US USD 3.91B 504M
Aptinyx Inc APTX:US USD 14.66M 2.45M
Baxter International BAX:US USD 6.57B 3.18B
Cara Therapeutics CARA:US USD 34.66M 7.18M
Cytokinetics CYTK:US USD 133.2M 33.36M
Eli Lilly And LLY:US USD 5.27B 12.8M
Esperion Therapeutics ESPR:US USD 60.6M 10.61M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Immunogen IMGN:US USD 92.8M 17.59M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Intra Cellular Therapies ITCI:US USD 127.5M 16M
Intrexon XON:US USD 24.34M 2.74M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
JAZZ PHA JAZZ:US USD 915.89M 68.56M
Mannkind MNKD:US USD 42.43M 3.09M
Minerva Neurosciences NERV:US USD 5.21M 1.76M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Peregrine Pharmaceuticals PPHM:US USD 33.96M 3.8M
Pfizer PFE:US USD 13.23B 2.41B
Rigel Pharmaceuticals RIGL:US USD 40.81M 1.97M
United Therapeutics UTHR:US USD 201.7M 63.4M
Vanda Pharmaceuticals VNDA:US USD 61.41M 481K